Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

A Combined Proteomics and Mendelian Randomization Approach to Investigate the Effects of Aspirin-Targeted Proteins on Colorectal Cancer.

Aayah Nounu | Alexander Greenhough | Kate J Heesom | Rebecca C Richmond | Jie Zheng | Stephanie J Weinstein | Demetrius Albanes | John A Baron | John L Hopper | Jane C Figueiredo | Polly A Newcomb | Noralane M Lindor | Graham Casey | Elizabeth A Platz | Loïc Le Marchand | Cornelia M Ulrich | Christopher I Li | Fränzel J B van Duijnhoven | Andrea Gsur | Peter T Campbell | Víctor Moreno | Pavel Vodicka | Ludmila Vodickova | Hermann Brenner | Jenny Chang-Claude | Michael Hoffmeister | Lori C Sakoda | Martha L Slattery | Robert E Schoen | Marc J Gunter | Sergi Castellví-Bel | Hyeong Rok Kim | Sun-Seog Kweon | Andrew T Chan | Li Li | Wei Zheng | D Timothy Bishop | Daniel D Buchanan | Graham G Giles | Stephen B Gruber | Gad Rennert | Zsofia K Stadler | Tabitha A Harrison | Yi Lin | Temitope O Keku | Michael O Woods | Clemens Schafmayer | Bethany Van Guelpen | Steven Gallinger | Heather Hampel | Sonja I Berndt | Paul D P Pharoah | Annika Lindblom | Alicja Wolk | Anna H Wu | Emily White | Ulrike Peters | David A Drew | Dominique Scherer | Justo Lorenzo Bermejo | Ann C Williams | Caroline L Relton
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology | 2021

Evidence for aspirin's chemopreventative properties on colorectal cancer (CRC) is substantial, but its mechanism of action is not well-understood. We combined a proteomic approach with Mendelian randomization (MR) to identify possible new aspirin targets that decrease CRC risk.

Pubmed ID: 33318029

Research resources used in this publication

Additional research tools detected in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R01 CA067941
  • Agency: NHGRI NIH HHS, United States
    Id: U01 HG004438
  • Agency: NHGRI NIH HHS, United States
    Id: U01 HG004446
  • Agency: NCI NIH HHS, United States
    Id: U10 CA037429
  • Agency: NCI NIH HHS, United States
    Id: K05 CA154337
  • Agency: NCI NIH HHS, United States
    Id: U01 CA164930
  • Agency: NCI NIH HHS, United States
    Id: P30 CA076292
  • Agency: NCI NIH HHS, United States
    Id: R01 CA042182
  • Agency: NCI NIH HHS, United States
    Id: P50 CA127003
  • Agency: NCI NIH HHS, United States
    Id: U01 CA067941
  • Agency: NCI NIH HHS, United States
    Id: R01 CA059045
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100001I
  • Agency: NCI NIH HHS, United States
    Id: R01 CA197350
  • Agency: NCI NIH HHS, United States
    Id: R01 CA076366
  • Agency: NCI NIH HHS, United States
    Id: R35 CA197735
  • Agency: NCI NIH HHS, United States
    Id: R01 CA072520
  • Agency: NCI NIH HHS, United States
    Id: P01 CA087969
  • Agency: NCI NIH HHS, United States
    Id: P30 CA015704
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100004I
  • Agency: NCI NIH HHS, United States
    Id: P30 CA006973
  • Agency: NCI NIH HHS, United States
    Id: U24 CA074783
  • Agency: NCI NIH HHS, United States
    Id: P01 CA055075
  • Agency: NIH HHS, United States
    Id: S10 OD028685
  • Agency: NCI NIH HHS, United States
    Id: R01 CA151993
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100046C
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK034987
  • Agency: NCI NIH HHS, United States
    Id: R01 CA048998
  • Agency: NCI NIH HHS, United States
    Id: U01 CA137088
  • Agency: Cancer Research UK, United Kingdom
    Id: 11975
  • Agency: NCI NIH HHS, United States
    Id: R01 CA189184
  • Agency: NCI NIH HHS, United States
    Id: U01 CA167552
  • Agency: WHI NIH HHS, United States
    Id: HHSN268201100003C
  • Agency: Medical Research Council, United Kingdom
    Id: MC_UU_12013_2
  • Agency: Intramural NIH HHS, United States
    Id: Z01 CP010200
  • Agency: NCI NIH HHS, United States
    Id: U24 CA074794
  • Agency: NCI NIH HHS, United States
    Id: R01 CA066635
  • Agency: NCI NIH HHS, United States
    Id: R21 CA191312
  • Agency: NCI NIH HHS, United States
    Id: U01 CA206110
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201200008C
  • Agency: Cancer Research UK, United Kingdom
    Id: C18281/A19169
  • Agency: NCI NIH HHS, United States
    Id: R01 CA137178
  • Agency: NCI NIH HHS, United States
    Id: U01 CA074794
  • Agency: NCI NIH HHS, United States
    Id: P30 CA008748
  • Agency: NCI NIH HHS, United States
    Id: U01 CA167551
  • Agency: NCI NIH HHS, United States
    Id: P30 CA014089
  • Agency: NCI NIH HHS, United States
    Id: R01 CA081488
  • Agency: NIA NIH HHS, United States
    Id: HHSN271201100004C
  • Agency: NCI NIH HHS, United States
    Id: R01 CA201407
  • Agency: NCI NIH HHS, United States
    Id: R01 CA063464
  • Agency: NCI NIH HHS, United States
    Id: P01 CA033619
  • Agency: NCI NIH HHS, United States
    Id: U01 CA086308
  • Agency: NCI NIH HHS, United States
    Id: UM1 CA186107
  • Agency: WHI NIH HHS, United States
    Id: HHSN268201100002C
  • Agency: NCI NIH HHS, United States
    Id: R01 CA207371
  • Agency: NCI NIH HHS, United States
    Id: R03 CA153323
  • Agency: NIEHS NIH HHS, United States
    Id: T32 ES013678
  • Agency: NCI NIH HHS, United States
    Id: R01 CA136726
  • Agency: NCI NIH HHS, United States
    Id: P30 CA016058
  • Agency: NCI NIH HHS, United States
    Id: UM1 CA167552
  • Agency: NCI NIH HHS, United States
    Id: K05 CA152715
  • Agency: NCI NIH HHS, United States
    Id: U01 CA122839
  • Agency: Wellcome Trust, United Kingdom
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100003I
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100002I
  • Agency: NCI NIH HHS, United States
    Id: U01 CA074783
  • Agency: NCI NIH HHS, United States
    Id: U01 CA084968
  • Agency: NCATS NIH HHS, United States
    Id: KL2 TR000421
  • Agency: Medical Research Council, United Kingdom
    Id: MR/R017247/1
  • Agency: NCI NIH HHS, United States
    Id: UM1 CA182883
  • Agency: NCI NIH HHS, United States
    Id: K07 CA190673
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201200008I
  • Agency: Wellcome Trust, United Kingdom
    Id: 217487/Z/19/Z
  • Agency: NCI NIH HHS, United States
    Id: U01 CA164973
  • Agency: NCI NIH HHS, United States
    Id: R37 CA054281
  • Agency: WHI NIH HHS, United States
    Id: HHSN268201100001C
  • Agency: WHI NIH HHS, United States
    Id: HHSN268201100004C
  • Agency: NCI NIH HHS, United States
    Id: R01 CA097325
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201700006C
  • Agency: NCI NIH HHS, United States
    Id: U19 CA148107
  • Agency: NIA NIH HHS, United States
    Id: U01 AG018033

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


S/RG/C2 (cell line)

RRID:CVCL_IQ11

Cell line S/RG/C2 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions